Clinical trials: HIV-DDI

HIV-DDI

Interaction With HIV Antiretroviral Agents

• Completed
• Age: 18 to 65 years
• Phase 1
• Pill or oral medicine

To investigate the pharmacokinetic drug-drug interaction potential of fixed dose antiretroviral therapies, i.e. ATRIPLA, COMPLERA, STRIBILD, TRIUMEQ, or any approved antiretroviral protease inhibitor in combination with…

Trial name

NCT02556268

Testing

Riociguat (Adempas, BAY 63-2521), ATRIPLA, COMPLERA

Where

2 sites in United States

Volunteers

40 people

Sponsor

Bayer